Researchers have developed small molecules to combat deadly, drug-resistant enterococcus.

Scientists say they have found a new way to kill some multiplying human breast cancer cells by selectively […]

Roche’s new approval Enspryng cuts relapse risk in NMOSD—and provides extended benefits esagonowsky Thu, 09/10/2020 – 09:55

AstraZeneca chases GSK, Sanofi and Regeneron with Fasenra trial win in nasal polyps aliu Thu, 09/10/2020 – 09:44

GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients kblankenship Thu, 09/10/2020 – 08:37

Vaccination persuasion: Personal stories most likely to influence people toward COVID-19 shots, analytics firm finds bbulik Wed, 09/09/2020 […]

Trelegy Ellipta is now the first once-daily single inhaler triple therapy for the treatment of both asthma and […]

The EMA has asked for full data from an ongoing Phase III study of the treatment in patients […]

The proposed deal covers the initial supply of 200 million doses and an option to purchase an additional […]

The UK government grant will support new and existing advanced therapy projects until March 2022